Chimerism of avian IgY‐scFv and truncated IgG‐Fc : A novel strategy in cross‐species antibody generation and enhancement
Immunology · 2024-05 · 172 (1) · 46-60
DOI: 10.1111/imm.13752 ↗At a glance
Journal article in Immunology, published online on 2024-01-21. Written by Shikun Ge and 2 co-authors. Institution: Department of Biology, Centre of Molecular and Environmental Biology, University of Minho, Braga, Portugal. Major MEDLINE topics: Immunoglobulin G, Chimerism, Immunoglobulins. Cited 10 times so far (Crossref); 65 references. Funded by: European Regional Development Fund (ERDF), National Natural Science Foundation of China, FCT I.P, the Ministério da Ciência Tecnologia e Ensino Superior (MCTES).
Abstract (original language)
Chicken single‐chain fragment variable (IgY‐scFv) is a functional fragment and an emerging development in genetically engineered antibodies with a wide range of biomedical applications. However, scFvs have considerably shorter serum half‐life due to the absence of antibody Fc region compared with the full‐length antibody, and usually requires continuous intravenous administration for efficacy. A promising approach to overcome this limitation is to fuse scFv with immunoglobulin G (IgG) Fc region, for better recognition and mediation by the neonatal Fc receptor (FcRn) in the host. In this study, engineered mammalian ΔFc domains (CH2, CH3, and intact Fc region) were fused with anti‐canine parvovirus‐like particles avian IgY‐scFv to produce chimeric antibodies and expressed in the HEK293 cell expression system. The obtained scFv‐CH2, scFv‐CH3, and scFv‐Fc can bind with antigen specifically and dose‐dependently. Surface plasmon resonance investigation confirmed that scFv‐CH2, scFv‐CH3, and scFv‐Fc had different degrees of binding to FcRn, with scFv‐Fc showing the highest affinity. scFv‐Fc had a significantly longer half‐life in mice compared with the unfused scFv. The identified ΔFcs are promising for the development of engineered Fc‐based therapeutic antibodies and proteins with longer half‐lives. The avian IgY‐scFv‐mammalian IgG Fc region opens up new avenues for antibody engineering, and it is a novel strategy to enhance the rapid development and screening of functional antibodies in veterinary and human medicine.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Biology, Centre of Molecular and Environmental Biology, University of Minho, Braga, Portugal.
- College of Biological Science and Engineering, Shaanxi University of Technology, Hanzhong, China.
- Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Ontario, Canada.
ORCID profiles: Xiaoying Zhang
Funding
- European Regional Development Fund (ERDF)
- National Natural Science Foundation of China
- FCT I.P, the Ministério da Ciência Tecnologia e Ensino Superior (MCTES)
Cite
APA
Ge, S., Dias, A. C. P., & Zhang, X. (2024). Chimerism of avian IgY‐scFv and truncated IgG‐Fc : A novel strategy in cross‐species antibody generation and enhancement. Immunology, 172(1), 46-60. https://doi.org/10.1111/imm.13752
Vancouver
Ge S, Dias ACP, Zhang X. Chimerism of avian IgY‐scFv and truncated IgG‐Fc : A novel strategy in cross‐species antibody generation and enhancement. Immunology. 2024;172(1):46-60. doi:10.1111/imm.13752
BibTeX
@article{Ge2024,
author = {Ge, Shikun and Dias, Alberto Carlos Pires and Zhang, Xiaoying},
title = {Chimerism of avian IgY‐scFv and truncated IgG‐Fc : A novel strategy in cross‐species antibody generation and enhancement},
journal = {Immunology},
year = {2024},
volume = {172},
number = {1},
pages = {46--60},
doi = {10.1111/imm.13752}
}
EUVIMED